RXO Inc: Stifel raises target price to $30 from $22
RXO•Related News
Q32 Bio soars as hair-loss drug shows scalp hair regrowth in mid-stage study
QTTB•
Neurocrine Biosciences, Inc <NBIX.O>: BMO Raises Target Price to $170 From $144
NBIX•
T Rowe Price Group Inc <TROW.O>: BMO Raises Target Price to $124 From $110
TROW•
Saia Inc <SAIA.O>: Raymond James Cuts Target Price to $475 From $477
SAIA•
Ares Management Corp <ARES.N>: BMO raises target price to $128 from $125
ARES•